Putative atypical antipsychotics with mixed dopaminergic (D1, D2) and serotonergic (5HT2) activity: The design evolution of ZD3638

This publication has 21 references indexed in Scilit:

• Pitfalls and Problems of the Long Term Use of Neuroleptic Drugs in Schizophrenia
  Drug Safety, 1993
• Neurochemistry and Neuroendocrinology of Schizophrenia: A Selective Review
  Schizophrenia Bulletin, 1993
• Dopamine in schizophrenia: a review and reconceptualization
  American Journal of Psychiatry, 1991
• The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine
  European Journal of Pharmacology, 1991
• CY 208–243 behaves as a typical D-1 agonist in the reserpine-treated mouse
  Pharmacology Biochemistry and Behavior, 1991
• The interaction of clozapine with dopamine D1 versus dopamine D2 receptor-mediated function: behavioural indices
  European Journal of Pharmacology, 1990
• Differential behavioural interactions between the dopamine D-1 antagonist SCH 23390 and the dopamine D-2 antagonists metoclopramide and sulpiride in nonhabituated mice
  Pharmacology Biochemistry and Behavior, 1990
• Drugs acting on brain dopamine receptors: A conceptual re-evaluation five years after the first selective D-1 antagonist
  Pharmacology & Therapeutics, 1989
• Clozapine for the Treatment-Resistant Schizophrenic
  Archives of General Psychiatry, 1988
• Perspectives on the Discovery of Central Monoaminergic Neurotransmission
  Annual Review of Neuroscience, 1987